Patent · US Active

Factor VIII polymer conjugates

US11020458B2 · kind B2 · utility

9Cited by

46References

1Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Peter Turecek · Klosterneuburg, AT
Juergen Siekmann · Wien, AT

Key dates

Filing date	Feb 26, 2019
Grant date	Jun 1, 2021
Priority date	—
Expiry date	Mar 22, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.